| Q50083987 | A multicentre study of antifungal susceptibility patterns among 350 Candida auris isolates (2009-17) in India: role of the ERG11 and FKS1 genes in azole and echinocandin resistance. |
| Q92404341 | ABC Transporter Genes Show Upregulated Expression in Drug-Resistant Clinical Isolates of Candida auris: A Genome-Wide Characterization of ATP-Binding Cassette (ABC) Transporter Genes |
| Q90402506 | Amplified fragment length polymorphism and whole genome sequencing: a comparison of methods in the investigation of a nosocomial outbreak with vancomycin resistant enterococci |
| Q90618019 | Antifungal Resistance: Specific Focus on Multidrug Resistance in Candida auris and Secondary Azole Resistance in Aspergillus fumigatus |
| Q41987164 | Approach to the investigation and management of patients with Candida auris, an emerging multidrug-resistant yeast |
| Q47205366 | Biofilms and beyond: expanding echinocandin utility |
| Q50113587 | Breakthrough candidemia after the introduction of broad spectrum antifungal agents: A 5-year retrospective study |
| Q92859506 | Candida auris Biofilm Colonization on Skin Niche Conditions |
| Q92859499 | Candida auris Forms High-Burden Biofilms in Skin Niche Conditions and on Porcine Skin |
| Q55669785 | Candida auris colonization in an immunocompetent patient: A new threat in medical ICU. |
| Q53704744 | Candida auris for the clinical microbiology laboratory: Not your grandfather's Candida species. |
| Q92927244 | Candida auris in Germany and Previous Exposure to Foreign Healthcare |
| Q58794314 | Candida auris in Healthcare Facilities, New York, USA, 2013-2017 |
| Q92339780 | Candida auris in a U.S. Patient with Carbapenemase-Producing Organisms and Recent Hospitalization in Kenya |
| Q98170039 | Candida auris in the UK: Introduction, dissemination, and control |
| Q89510130 | Candida auris, an Agent of Hospital-Associated Outbreaks: Which Challenging Issues Do We Need to Have in Mind? |
| Q51149128 | Candida auris, what do paediatricians need to know? |
| Q89944189 | Candida auris: A Decade of Understanding of an Enigmatic Pathogenic Yeast |
| Q91643627 | Candida auris: A Review of Recommendations for Detection and Control in Healthcare Settings |
| Q33704302 | Candida auris: A rapidly emerging cause of hospital-acquired multidrug-resistant fungal infections globally |
| Q48220845 | Candida auris: A systematic review and meta-analysis of current updates on an emerging multidrug-resistant pathogen |
| Q46255772 | Candida auris: An Emerging Fungal Pathogen |
| Q64068234 | Candida auris: An emerging pathogen "incognito"? |
| Q53690366 | Candida auris: Disinfectants and Implications for Infection Control. |
| Q95642098 | Candida auris: From Multidrug Resistance to Pan-Resistant Strains |
| Q49988058 | Candida auris: a Review of the Literature. |
| Q39092282 | Candida auris: a worrisome, globally emerging pathogen |
| Q40064579 | Candidiasis and the impact of flow cytometry on antifungal drug discovery. |
| Q47749844 | Changes in the epidemiological landscape of invasive candidiasis. |
| Q90610965 | Clade II Candida auris possess genomic structural variations related to an ancestral strain |
| Q64064934 | Clinical spectrum and factors impacting outcome of Candida auris: a single center study from Pakistan |
| Q92320618 | Combined Antifungal Resistance and Biofilm Tolerance: the Global Threat of Candida auris |
| Q50128552 | Containment strategies to address the expanding threat of multidrug-resistant Candida auris |
| Q33812143 | Current perspective on emergence, diagnosis and drug resistance in Candida auris |
| Q92479570 | Development of Candida auris Short Tandem Repeat Typing and Its Application to a Global Collection of Isolates |
| Q92543621 | Does Online Search Behavior Coincide with Candida auris Cases? An Exploratory Study |
| Q38798805 | Drug development challenges and strategies to address emerging and resistant fungal pathogens |
| Q39092133 | Effectiveness of Disinfectants Against Candida auris and Other Candida Species |
| Q92707855 | Efficacy of Delayed Therapy with Fosmanogepix (APX001) in a Murine Model of Candida auris Invasive Candidiasis |
| Q48721573 | Emergence of Candida auris: An International Call to Arms |
| Q58730092 | Emerging Fungal Pathogen Candida auris Evades Neutrophil Attack |
| Q92812046 | Epidemiologic Shift in Candidemia Driven by Candida auris, South Africa, 2016-20171 |
| Q58598193 | Epidemiology, clinical characteristics, resistance, and treatment of infections by |
| Q114115328 | Eradication of Fungi Using MoSe2/Chitosan Nanosheets |
| Q89088418 | Evaluation of the efficacy of rezafungin, a novel echinocandin, in the treatment of disseminated Candida auris infection using an immunocompromised mouse model |
| Q90574312 | External Quality Assessment Evaluating the Ability of Dutch Clinical Microbiological Laboratories to Identify Candida auris |
| Q59804393 | Filamentation in Candida auris, an emerging fungal pathogen of humans: passage through the mammalian body induces a heritable phenotypic switch |
| Q90124888 | First Report of Candida auris Spondylodiscitis in Oman: A Rare Presentation |
| Q55547464 | First cases and risk factors of super yeast Candida auris infection or colonization from Shenyang, China. |
| Q55017741 | First reported case of multidrug-resistant Candida auris in Canada. |
| Q39092120 | Fluconazole resistance in Candida species: a current perspective |
| Q110951300 | From environmental adaptation to host survival: Attributes that mediate pathogenicity of Candida auris |
| Q52611998 | Fungicidal potency and mechanisms of θ-defensins against multi-drug resistant Candida species. |
| Q40045680 | Future Research Priorities in Fungal Resistance |
| Q49679927 | Gaining Insights from Candida Biofilm Heterogeneity: One Size Does Not Fit All. |
| Q96155834 | Genetic Heterogeneity of Australian Candida auris Isolates: Insights From a Nonoutbreak Setting Using Whole-Genome Sequencing |
| Q51782762 | Genomic epidemiology of the UK outbreak of the emerging human fungal pathogen Candida auris. |
| Q60044502 | Genomic insights into multidrug-resistance, mating and virulence in Candida auris and related emerging species |
| Q92058439 | Global Screening of Genomic and Transcriptomic Factors Associated with Phenotype Differences between Multidrug-Resistant and -Susceptible Candida haemulonii Strains |
| Q47646997 | Global and Multi-National Prevalence of Fungal Diseases-Estimate Precision |
| Q51782681 | Healthcare-associated fungal outbreaks: New and uncommon species, New molecular tools for investigation and prevention. |
| Q39396781 | High-touch surfaces: microbial neighbours at hand. |
| Q57793431 | Hog1 Regulates Stress Tolerance and Virulence in the Emerging Fungal Pathogen Candida auris |
| Q64226654 | Identification and Rapid Antifungal Susceptibility Testing Against Echinocandins by MALDI-TOF MS |
| Q56993529 | Identification of Antifungal Targets Based on Computer Modeling |
| Q92622922 | Identification of Candida auris by Use of the Updated Vitek 2 Yeast Identification System, Version 8.01: a Multilaboratory Evaluation Study |
| Q93088245 | Identification of Drug Resistant Candida auris |
| Q64084323 | Identification of Off-Patent Compounds That Present Antifungal Activity Against the Emerging Fungal Pathogen |
| Q40065391 | Importance of Resolving Fungal Nomenclature: the Case of Multiple Pathogenic Species in the Cryptococcus Genus. |
| Q39092177 | In Vitro Interactions of Echinocandins with Triazoles Against Multidrug-Resistant Candida auris |
| Q47195606 | In vitro and in vivo Evaluation of the Antifungal Activity of APX001A/APX001 Against Candida auris |
| Q92039317 | In vitro antifungal activity of a novel topical triazole PC945 against emerging yeast Candida auris |
| Q39092094 | In vitro efficacy of disinfectants utilised for skin decolonization and environmental decontamination during a hospital outbreak with Candida auris. |
| Q41986535 | Increasing candidemia incidence from 2004 to 2015 with a shift in epidemiology in patients pre-exposed to antifungals |
| Q52598778 | Increasing prevalence, molecular characterization and antifungal drug susceptibility of serial Candida auris isolates in Kuwait. |
| Q92075140 | Indifferent effect of nonsteroidal anti-inflammatory drugs (NSAIDs) combined with fluconazole against multidrug-resistant Candida auris |
| Q89288908 | Invasive Candida auris infections in Kuwait hospitals: epidemiology, antifungal treatment and outcome |
| Q64242716 | Investigating Antifungal Susceptibility in Species With MALDI-TOF MS-Based Assays |
| Q39092367 | Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016. |
| Q50985111 | Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus-United States, May 2013-August 2016. |
| Q90280509 | Isolation of Candida auris from Ear of Otherwise Healthy Patient, Austria, 2018 |
| Q92142505 | Isolation of Candida auris from cystic fibrosis patient, Greece, April 2019 |
| Q98936603 | Management of Candida auris outbreak in a tertiary-care setting in Saudi Arabia |
| Q92752608 | Molecular Diagnostics in the Times of Surveillance for Candida auris |
| Q37653894 | Molecular Fingerprinting Studies Do Not Support Intrahospital Transmission of Candida albicans among Candidemia Patients in Kuwait |
| Q92652689 | Molecular Identification, Genotypic Diversity, Antifungal Susceptibility, and Clinical Outcomes of Infections Caused by Clinically Underrated Yeasts, Candida orthopsilosis, and Candida metapsilosis: An Iranian Multicenter Study (2014-2019) |
| Q92666321 | Multi-omics Signature of Candida auris, an Emerging and Multidrug-Resistant Pathogen |
| Q40040802 | Multidrug-Resistant Candida: Epidemiology, Molecular Mechanisms, and Treatment. |
| Q57187360 | Multiple introductions and subsequent transmission of multidrug-resistant Candida auris in the USA: a molecular epidemiological survey |
| Q64359214 | New and emerging infectious diseases (Ebola, Middle Eastern respiratory syndrome coronavirus, carbapenem-resistant Enterobacteriaceae, Candida auris): Focus on environmental survival and germicide susceptibility |
| Q94464436 | Nine Things Genomics Can Tell Us About Candida auris |
| Q91620123 | Nucleic acids enrichment of fungal pathogens to study host-pathogen interactions |
| Q50046031 | Oligonucleotide Array and VITEK Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry in Species Identification of Blood Yeast Isolates |
| Q91715567 | On the Origins of a Species: What Might Explain the Rise of Candida auris? |
| Q38404103 | Otomastoiditis caused by Candida auris: Case report and literature review |
| Q39092240 | Pharmacodynamic Optimization for Treatment of Invasive Candida auris Infection |
| Q90305479 | Population-Based Active Surveillance for Culture-Confirmed Candidemia - Four Sites, United States, 2012-2016 |
| Q48155956 | Primary prophylaxis of invasive fungal infections in patients with haematological malignancies: 2017 update of the recommendations of the Infectious Diseases Working Party (AGIHO) of the German Society for Haematology and Medical Oncology (DGHO). |
| Q64911580 | Rapid Detection of Candida auris Based on Loop-Mediated Isothermal Amplification (LAMP). |
| Q39092215 | Rapid and Accurate Molecular Identification of the Emerging Multidrug-Resistant Pathogen Candida auris |
| Q90291132 | Rapid and extensive karyotype diversification in haploid clinical Candida auris isolates |
| Q46258749 | Rare fungal infectious agents: a lurking enemy. |
| Q90460596 | Repositionable Compounds with Antifungal Activity against Multidrug Resistant Candida auris Identified in the Medicines for Malaria Venture's Pathogen Box |
| Q92071802 | Review on Antifungal Resistance Mechanisms in the Emerging Pathogen Candida auris |
| Q92540203 | Role of lipid transporters in fungal physiology and pathogenicity |
| Q90663373 | Single-tube, dual channel pentaplexing for the identification of Candida strains associated with human infection |
| Q93166142 | Something wicked this way comes: What health care providers need to know about Candida auris |
| Q92624371 | Successful treatment of a Candida auris intra-articular infection |
| Q38659451 | Survival, Persistence, and Isolation of the Emerging Multidrug-Resistant Pathogenic Yeast Candida auris on a Plastic Healthcare Surface |
| Q91612680 | Susceptibility of Candida auris and Candida albicans to 21 germicides used in healthcare facilities |
| Q49489254 | The Candida auris Alert: Facts and Perspectives |
| Q38949297 | The Emerging Pathogen Candida auris: Growth Phenotype, Virulence Factors, Activity of Antifungals, and Effect of SCY-078, a Novel Glucan Synthesis Inhibitor, on Growth Morphology and Biofilm Formation. |
| Q50194392 | The Emerging Threat of Antifungal Resistance in Transplant Infectious Diseases |
| Q90418831 | The First Two Cases of Candida auris in The Netherlands |
| Q88499092 | The Role of Environmental Contamination in the Transmission of Nosocomial Pathogens and Healthcare-Associated Infections |
| Q64886746 | The efficacy of pulsed-xenon ultraviolet light technology on Candida auris. |
| Q46255428 | The hidden pathogenic potential of environmental fungi |
| Q57296241 | The mycoparasitic yeast Saccharomycopsis schoenii predates and kills multi-drug resistant Candida auris |
| Q40048044 | Thinking beyond the Common Candida Species: Need for Species-Level Identification of Candida Due to the Emergence of Multidrug-Resistant Candida auris |
| Q94451620 | Tracing the Evolutionary History and Global Expansion of Candida auris Using Population Genomic Analyses |
| Q98665147 | Transcriptional and functional insights into the host immune response against the emerging fungal pathogen Candida auris |
| Q55689919 | Transcriptome Assembly and Profiling of Candida auris Reveals Novel Insights into Biofilm-Mediated Resistance. |
| Q90204317 | Translation Inhibition by Rocaglates Activates a Species-Specific Cell Death Program in the Emerging Fungal Pathogen Candida auris |
| Q52597955 | Understanding echinocandin resistance in the emerging pathogen Candida auris. |
| Q33823090 | Use of RNA-Protein Complexes for Genome Editing in Non-albicans Candida Species |
| Q64921062 | Viability of Candida auris and Other Candida Species after Various Matrix-Assisted Laser Desorption Ionization-Time of Flight (MALDI-TOF) Mass Spectrometry-Based Extraction Protocols. |
| Q60958254 | What Have We Learned About Its Mechanisms of Pathogenicity? |
| Q47749829 | What has changed in the treatment of invasive candidiasis? A look at the past 10 years and ahead. |
| Q90706869 | [Candida auris: estrategias y retos para prevenir un brote] |